Global Gene-based Therapy Medicinal Market Research Report 2026(Status and Outlook)

May 2026 | 151 pages | ID: G65711A69E42EN
Bosson Research

Abstracts

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.

The global Gene-based Therapy Medicinal market size was estimated at USD 14300.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 26.00% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Gene-based Therapy Medicinal market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Gene-based Therapy Medicinal market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene-based Therapy Medicinal market.

Global Gene-based Therapy Medicinal Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Biogen
• Novartis
• Gilead Sciences
• Sarepta Therapeutics
• Alnylam Pharmaceuticals
• Amgen
• Spark Therapeutics
• Akcea Therapeutics
• Sunway Biotech
• SIBIONO
• AnGes
• Orchard Therapeutics
• Human Stem Cells Institute

Market Segmentation (by Type)

• Viral Gene Delivery System
• Non-viral Gene Delivery System

Market Segmentation (by Application)

• Neurological Diseases
• Cancer
• Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Gene-based Therapy Medicinal Market

Overview of the regional outlook of the Gene-based Therapy Medicinal Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene-based Therapy Medicinal Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Gene-based Therapy Medicinal, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Gene-based Therapy Medicinal
1.2 Key Market Segments
  1.2.1 Gene-based Therapy Medicinal Segment by Type
  1.2.2 Gene-based Therapy Medicinal Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GENE-BASED THERAPY MEDICINAL MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Gene-based Therapy Medicinal Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Gene-based Therapy Medicinal Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GENE-BASED THERAPY MEDICINAL MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Gene-based Therapy Medicinal Product Life Cycle
3.3 Global Gene-based Therapy Medicinal Sales by Manufacturers (2020-2025)
3.4 Global Gene-based Therapy Medicinal Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene-based Therapy Medicinal Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Gene-based Therapy Medicinal Market Competitive Situation and Trends
  3.8.1 Gene-based Therapy Medicinal Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Gene-based Therapy Medicinal Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 GENE-BASED THERAPY MEDICINAL INDUSTRY CHAIN ANALYSIS

4.1 Gene-based Therapy Medicinal Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF GENE-BASED THERAPY MEDICINAL MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Gene-based Therapy Medicinal Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Gene-based Therapy Medicinal Market
5.7 ESG Ratings of Leading Companies

6 GENE-BASED THERAPY MEDICINAL MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene-based Therapy Medicinal Sales Market Share by Type (2020-2025)
6.3 Global Gene-based Therapy Medicinal Market Size by Type (2020-2025)
6.4 Global Gene-based Therapy Medicinal Price by Type (2020-2025)

7 GENE-BASED THERAPY MEDICINAL MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene-based Therapy Medicinal Market Sales by Application (2020-2025)
7.3 Global Gene-based Therapy Medicinal Market Size (M USD) by Application (2020-2025)
7.4 Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2020-2025)

8 GENE-BASED THERAPY MEDICINAL MARKET SALES BY REGION

8.1 Global Gene-based Therapy Medicinal Sales by Region
  8.1.1 Global Gene-based Therapy Medicinal Sales by Region
  8.1.2 Global Gene-based Therapy Medicinal Sales Market Share by Region
8.2 Global Gene-based Therapy Medicinal Market Size by Region
  8.2.1 Global Gene-based Therapy Medicinal Market Size by Region
  8.2.2 Global Gene-based Therapy Medicinal Market Size by Region
8.3 North America
  8.3.1 North America Gene-based Therapy Medicinal Sales by Country
  8.3.2 North America Gene-based Therapy Medicinal Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Gene-based Therapy Medicinal Sales by Country
  8.4.2 Europe Gene-based Therapy Medicinal Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Gene-based Therapy Medicinal Sales by Region
  8.5.2 Asia Pacific Gene-based Therapy Medicinal Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Gene-based Therapy Medicinal Sales by Country
  8.6.2 South America Gene-based Therapy Medicinal Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Gene-based Therapy Medicinal Sales by Region
  8.7.2 Middle East and Africa Gene-based Therapy Medicinal Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 GENE-BASED THERAPY MEDICINAL MARKET PRODUCTION BY REGION

9.1 Global Production of Gene-based Therapy Medicinal by Region(2020-2025)
9.2 Global Gene-based Therapy Medicinal Revenue Market Share by Region (2020-2025)
9.3 Global Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene-based Therapy Medicinal Production
  9.4.1 North America Gene-based Therapy Medicinal Production Growth Rate (2020-2025)
  9.4.2 North America Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene-based Therapy Medicinal Production
  9.5.1 Europe Gene-based Therapy Medicinal Production Growth Rate (2020-2025)
  9.5.2 Europe Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene-based Therapy Medicinal Production (2020-2025)
  9.6.1 Japan Gene-based Therapy Medicinal Production Growth Rate (2020-2025)
  9.6.2 Japan Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene-based Therapy Medicinal Production (2020-2025)
  9.7.1 China Gene-based Therapy Medicinal Production Growth Rate (2020-2025)
  9.7.2 China Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Biogen
  10.1.1 Biogen Basic Information
  10.1.2 Biogen Gene-based Therapy Medicinal Product Overview
  10.1.3 Biogen Gene-based Therapy Medicinal Product Market Performance
  10.1.4 Biogen Business Overview
  10.1.5 Biogen SWOT Analysis
  10.1.6 Biogen Recent Developments
10.2 Novartis
  10.2.1 Novartis Basic Information
  10.2.2 Novartis Gene-based Therapy Medicinal Product Overview
  10.2.3 Novartis Gene-based Therapy Medicinal Product Market Performance
  10.2.4 Novartis Business Overview
  10.2.5 Novartis SWOT Analysis
  10.2.6 Novartis Recent Developments
10.3 Gilead Sciences
  10.3.1 Gilead Sciences Basic Information
  10.3.2 Gilead Sciences Gene-based Therapy Medicinal Product Overview
  10.3.3 Gilead Sciences Gene-based Therapy Medicinal Product Market Performance
  10.3.4 Gilead Sciences Business Overview
  10.3.5 Gilead Sciences SWOT Analysis
  10.3.6 Gilead Sciences Recent Developments
10.4 Sarepta Therapeutics
  10.4.1 Sarepta Therapeutics Basic Information
  10.4.2 Sarepta Therapeutics Gene-based Therapy Medicinal Product Overview
  10.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Product Market Performance
  10.4.4 Sarepta Therapeutics Business Overview
  10.4.5 Sarepta Therapeutics Recent Developments
10.5 Alnylam Pharmaceuticals
  10.5.1 Alnylam Pharmaceuticals Basic Information
  10.5.2 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Overview
  10.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Market Performance
  10.5.4 Alnylam Pharmaceuticals Business Overview
  10.5.5 Alnylam Pharmaceuticals Recent Developments
10.6 Amgen
  10.6.1 Amgen Basic Information
  10.6.2 Amgen Gene-based Therapy Medicinal Product Overview
  10.6.3 Amgen Gene-based Therapy Medicinal Product Market Performance
  10.6.4 Amgen Business Overview
  10.6.5 Amgen Recent Developments
10.7 Spark Therapeutics
  10.7.1 Spark Therapeutics Basic Information
  10.7.2 Spark Therapeutics Gene-based Therapy Medicinal Product Overview
  10.7.3 Spark Therapeutics Gene-based Therapy Medicinal Product Market Performance
  10.7.4 Spark Therapeutics Business Overview
  10.7.5 Spark Therapeutics Recent Developments
10.8 Akcea Therapeutics
  10.8.1 Akcea Therapeutics Basic Information
  10.8.2 Akcea Therapeutics Gene-based Therapy Medicinal Product Overview
  10.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Product Market Performance
  10.8.4 Akcea Therapeutics Business Overview
  10.8.5 Akcea Therapeutics Recent Developments
10.9 Sunway Biotech
  10.9.1 Sunway Biotech Basic Information
  10.9.2 Sunway Biotech Gene-based Therapy Medicinal Product Overview
  10.9.3 Sunway Biotech Gene-based Therapy Medicinal Product Market Performance
  10.9.4 Sunway Biotech Business Overview
  10.9.5 Sunway Biotech Recent Developments
10.10 SIBIONO
  10.10.1 SIBIONO Basic Information
  10.10.2 SIBIONO Gene-based Therapy Medicinal Product Overview
  10.10.3 SIBIONO Gene-based Therapy Medicinal Product Market Performance
  10.10.4 SIBIONO Business Overview
  10.10.5 SIBIONO Recent Developments
10.11 AnGes
  10.11.1 AnGes Basic Information
  10.11.2 AnGes Gene-based Therapy Medicinal Product Overview
  10.11.3 AnGes Gene-based Therapy Medicinal Product Market Performance
  10.11.4 AnGes Business Overview
  10.11.5 AnGes Recent Developments
10.12 Orchard Therapeutics
  10.12.1 Orchard Therapeutics Basic Information
  10.12.2 Orchard Therapeutics Gene-based Therapy Medicinal Product Overview
  10.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Product Market Performance
  10.12.4 Orchard Therapeutics Business Overview
  10.12.5 Orchard Therapeutics Recent Developments
10.13 Human Stem Cells Institute
  10.13.1 Human Stem Cells Institute Basic Information
  10.13.2 Human Stem Cells Institute Gene-based Therapy Medicinal Product Overview
  10.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Product Market Performance
  10.13.4 Human Stem Cells Institute Business Overview
  10.13.5 Human Stem Cells Institute Recent Developments

11 GENE-BASED THERAPY MEDICINAL MARKET FORECAST BY REGION

11.1 Global Gene-based Therapy Medicinal Market Size Forecast
11.2 Global Gene-based Therapy Medicinal Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Gene-based Therapy Medicinal Market Size Forecast by Country
  11.2.3 Asia Pacific Gene-based Therapy Medicinal Market Size Forecast by Region
  11.2.4 South America Gene-based Therapy Medicinal Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Gene-based Therapy Medicinal by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Gene-based Therapy Medicinal Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Gene-based Therapy Medicinal by Type (2026-2035)
  12.1.2 Global Gene-based Therapy Medicinal Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Gene-based Therapy Medicinal by Type (2026-2035)
12.2 Global Gene-based Therapy Medicinal Market Forecast by Application (2026-2035)
  12.2.1 Global Gene-based Therapy Medicinal Sales (K MT) Forecast by Application
  12.2.2 Global Gene-based Therapy Medicinal Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene-based Therapy Medicinal Market Size by Type (M USD)
Table 4. Global Gene-based Therapy Medicinal Market Size by Application
Table 5. Gene-based Therapy Medicinal Market Size Comparison by Region (M USD)
Table 6. Global Gene-based Therapy Medicinal Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gene-based Therapy Medicinal Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene-based Therapy Medicinal Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene-based Therapy Medicinal Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Therapy Medicinal as of 2025)
Table 11. Global Market Gene-based Therapy Medicinal Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Gene-based Therapy Medicinal Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene-based Therapy Medicinal Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene-based Therapy Medicinal Sales by Type (K MT)
Table 27. Global Gene-based Therapy Medicinal Market Size by Type (M USD)
Table 28. Global Gene-based Therapy Medicinal Sales (K MT) by Type (2020-2025)
Table 29. Global Gene-based Therapy Medicinal Sales Market Share by Type (2020-2025)
Table 30. Global Gene-based Therapy Medicinal Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene-based Therapy Medicinal Market Share by Type (2020-2025)
Table 32. Global Gene-based Therapy Medicinal Price (USD/KG) by Type (2020-2025)
Table 33. Global Gene-based Therapy Medicinal Sales (K MT) by Application
Table 34. Global Gene-based Therapy Medicinal Market Size by Application
Table 35. Global Gene-based Therapy Medicinal Sales by Application (2020-2025) & (K MT)
Table 36. Global Gene-based Therapy Medicinal Sales Market Share by Application (2020-2025)
Table 37. Global Gene-based Therapy Medicinal Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene-based Therapy Medicinal Market Share by Application (2020-2025)
Table 39. Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene-based Therapy Medicinal Sales by Region (2020-2025) & (K MT)
Table 41. Global Gene-based Therapy Medicinal Sales Market Share by Region (2020-2025)
Table 42. Global Gene-based Therapy Medicinal Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene-based Therapy Medicinal Market Size by Region (2020-2025)
Table 44. North America Gene-based Therapy Medicinal Sales by Country (2020-2025) & (K MT)
Table 45. North America Gene-based Therapy Medicinal Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene-based Therapy Medicinal Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gene-based Therapy Medicinal Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene-based Therapy Medicinal Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gene-based Therapy Medicinal Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene-based Therapy Medicinal Sales by Country (2020-2025) & (K MT)
Table 51. South America Gene-based Therapy Medicinal Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene-based Therapy Medicinal Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gene-based Therapy Medicinal Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene-based Therapy Medicinal Production (K MT) by Region(2020-2025)
Table 55. Global Gene-based Therapy Medicinal Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene-based Therapy Medicinal Revenue Market Share by Region (2020-2025)
Table 57. Global Gene-based Therapy Medicinal Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gene-based Therapy Medicinal Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gene-based Therapy Medicinal Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gene-based Therapy Medicinal Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gene-based Therapy Medicinal Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Biogen Basic Information
Table 63. Biogen Gene-based Therapy Medicinal Product Overview
Table 64. Biogen Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Biogen Business Overview
Table 66. Biogen SWOT Analysis
Table 67. Biogen Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Gene-based Therapy Medicinal Product Overview
Table 70. Novartis Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Gilead Sciences Basic Information
Table 75. Gilead Sciences Gene-based Therapy Medicinal Product Overview
Table 76. Gilead Sciences Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences SWOT Analysis
Table 79. Gilead Sciences Recent Developments
Table 80. Sarepta Therapeutics Basic Information
Table 81. Sarepta Therapeutics Gene-based Therapy Medicinal Product Overview
Table 82. Sarepta Therapeutics Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sarepta Therapeutics Business Overview
Table 84. Sarepta Therapeutics Recent Developments
Table 85. Alnylam Pharmaceuticals Basic Information
Table 86. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Overview
Table 87. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Alnylam Pharmaceuticals Business Overview
Table 89. Alnylam Pharmaceuticals Recent Developments
Table 90. Amgen Basic Information
Table 91. Amgen Gene-based Therapy Medicinal Product Overview
Table 92. Amgen Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Amgen Business Overview
Table 94. Amgen Recent Developments
Table 95. Spark Therapeutics Basic Information
Table 96. Spark Therapeutics Gene-based Therapy Medicinal Product Overview
Table 97. Spark Therapeutics Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Spark Therapeutics Business Overview
Table 99. Spark Therapeutics Recent Developments
Table 100. Akcea Therapeutics Basic Information
Table 101. Akcea Therapeutics Gene-based Therapy Medicinal Product Overview
Table 102. Akcea Therapeutics Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Akcea Therapeutics Business Overview
Table 104. Akcea Therapeutics Recent Developments
Table 105. Sunway Biotech Basic Information
Table 106. Sunway Biotech Gene-based Therapy Medicinal Product Overview
Table 107. Sunway Biotech Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sunway Biotech Business Overview
Table 109. Sunway Biotech Recent Developments
Table 110. SIBIONO Basic Information
Table 111. SIBIONO Gene-based Therapy Medicinal Product Overview
Table 112. SIBIONO Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. SIBIONO Business Overview
Table 114. SIBIONO Recent Developments
Table 115. AnGes Basic Information
Table 116. AnGes Gene-based Therapy Medicinal Product Overview
Table 117. AnGes Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. AnGes Business Overview
Table 119. AnGes Recent Developments
Table 120. Orchard Therapeutics Basic Information
Table 121. Orchard Therapeutics Gene-based Therapy Medicinal Product Overview
Table 122. Orchard Therapeutics Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Orchard Therapeutics Business Overview
Table 124. Orchard Therapeutics Recent Developments
Table 125. Human Stem Cells Institute Basic Information
Table 126. Human Stem Cells Institute Gene-based Therapy Medicinal Product Overview
Table 127. Human Stem Cells Institute Gene-based Therapy Medicinal Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Human Stem Cells Institute Business Overview
Table 129. Human Stem Cells Institute Recent Developments
Table 130. Global Gene-based Therapy Medicinal Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global Gene-based Therapy Medicinal Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Gene-based Therapy Medicinal Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America Gene-based Therapy Medicinal Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Gene-based Therapy Medicinal Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe Gene-based Therapy Medicinal Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Gene-based Therapy Medicinal Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific Gene-based Therapy Medicinal Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Gene-based Therapy Medicinal Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America Gene-based Therapy Medicinal Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Gene-based Therapy Medicinal Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Gene-based Therapy Medicinal Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Gene-based Therapy Medicinal Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global Gene-based Therapy Medicinal Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Gene-based Therapy Medicinal Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global Gene-based Therapy Medicinal Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global Gene-based Therapy Medicinal Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Gene-based Therapy Medicinal
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene-based Therapy Medicinal Market Size (M USD), 2025-2035
Figure 5. Global Gene-based Therapy Medicinal Market Size (M USD) (2020-2035)
Figure 6. Global Gene-based Therapy Medicinal Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene-based Therapy Medicinal Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene-based Therapy Medicinal Product Life Cycle
Figure 13. Gene-based Therapy Medicinal Sales Share by Manufacturers in 2025
Figure 14. Global Gene-based Therapy Medicinal Revenue Share by Manufacturers in 2025
Figure 15. Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene-based Therapy Medicinal Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene-based Therapy Medicinal Revenue in 2025
Figure 18. Industry Chain Map of Gene-based Therapy Medicinal
Figure 19. Global Gene-based Therapy Medicinal Market PEST Analysis
Figure 20. Global Gene-based Therapy Medicinal Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene-based Therapy Medicinal Market Share by Type
Figure 27. Sales Market Share of Gene-based Therapy Medicinal by Type (2020-2025)
Figure 28. Sales Market Share of Gene-based Therapy Medicinal by Type in 2025
Figure 29. Market Share of Gene-based Therapy Medicinal by Type (2020-2025)
Figure 30. Market Share of Gene-based Therapy Medicinal by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene-based Therapy Medicinal Market Share by Application
Figure 33. Global Gene-based Therapy Medicinal Sales Market Share by Application (2020-2025)
Figure 34. Global Gene-based Therapy Medicinal Sales Market Share by Application in 2025
Figure 35. Global Gene-based Therapy Medicinal Market Share by Application (2020-2025)
Figure 36. Global Gene-based Therapy Medicinal Market Share by Application in 2025
Figure 37. Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene-based Therapy Medicinal Sales Market Share by Region (2020-2025)
Figure 39. Global Gene-based Therapy Medicinal Market Size by Region (2020-2025)
Figure 40. North America Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gene-based Therapy Medicinal Sales Market Share by Country in 2024
Figure 43. North America Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene-based Therapy Medicinal Market Size by Country in 2024
Figure 45. U.S. Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene-based Therapy Medicinal Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gene-based Therapy Medicinal Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene-based Therapy Medicinal Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene-based Therapy Medicinal Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gene-based Therapy Medicinal Sales Market Share by Country in 2024
Figure 53. Europe Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene-based Therapy Medicinal Market Size by Country in 2024
Figure 55. Germany Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene-based Therapy Medicinal Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gene-based Therapy Medicinal Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene-based Therapy Medicinal Market Size by Region in 2024
Figure 68. China Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene-based Therapy Medicinal Sales and Growth Rate (K MT)
Figure 79. South America Gene-based Therapy Medicinal Sales Market Share by Country in 2024
Figure 80. South America Gene-based Therapy Medicinal Market Size and Growth Rate (M USD)
Figure 81. South America Gene-based Therapy Medicinal Market Size by Country in 2024
Figure 82. Brazil Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene-based Therapy Medicinal Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gene-based Therapy Medicinal Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene-based Therapy Medicinal Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene-based Therapy Medicinal Market Size by Region in 2024
Figure 92. Saudi Arabia Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene-based Therapy Medicinal Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gene-based Therapy Medicinal Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene-based Therapy Medicinal Production Market Share by Region (2020-2025)
Figure 103. North America Gene-based Therapy Medicinal Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gene-based Therapy Medicinal Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gene-based Therapy Medicinal Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gene-based Therapy Medicinal Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gene-based Therapy Medicinal Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gene-based Therapy Medicinal Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene-based Therapy Medicinal Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene-based Therapy Medicinal Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene-based Therapy Medicinal Sales Forecast by Application (2026-2035)
Figure 112. Global Gene-based Therapy Medicinal Market Share Forecast by Application (2026-2035)